Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: Twist bioscience corporation - The Untold Story

Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings

What if a biotech company could flip its financial narrative from loss to profit in just a year? Twist Bioscience Corporation (NASDAQ:TWST) has done just that, reporting a surprising third-quarter income that defied analysts’ expectations

Benzinga · Aug 4, 2025

First DNA Data Storage Specification Released: First Step Towards Commercialization

The DNA Data Storage Alliance introduced its inaugural specifications for DNA-based data storage this week. This specification outlines a method for encoding essential information within a DNA data archive, crucial for developing and commercializing an interoperable storage ecosystem. DNA data storage uses short strings of deoxyribonucleic acid (DNA) called oligonucleotides…

AnandTech · Mar 15, 2024

Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies

Twist Bioscience Corporation (NASDAQ:TWST) has entered into a research collaboration and exclusive option license agreement with Astellas Pharma Inc (OTC:ALPMF) to conduct research activities to identify and optimize proprietary Twist antagonist antibodies. The antibodies will target an undisclosed checkpoint inhibitor pathway in the tumor microenvironment as potential therapeutic development candidates. Ligands in this pathway are…

Benzinga · May 9, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Twist Bioscience Inks Antibody Discovery Pact With MediSix Therapeutics

Twist Bioscience Corporation (NASDAQ: TWST) and MediSix Therapeutics have collaborated to discover novel antibodies

Benzinga · Apr 7, 2022

Twist Bioscience Launches Synthetic RNA Positive Controls For SARS-CoV-2 Encapsulated Minicapsules

Twist Bioscience Corporation (NASDAQ: TWST) has

Benzinga · Mar 21, 2022

Twist Bioscience Raises $250M Via Equity Issued At 11% Discount

Twist Bioscience Corporation (NASDAQ: TWST) has priced its upsized underwritten public offering of

Benzinga · Feb 11, 2022

Coverage From

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.